James Roede
Concepts (325)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 6 | 2023 | 534 | 2.400 |
Why?
| | Mitochondria | 10 | 2023 | 984 | 2.080 |
Why?
| | Maneb | 4 | 2020 | 9 | 1.980 |
Why?
| | Sulfhydryl Compounds | 8 | 2025 | 189 | 1.800 |
Why?
| | Induced Pluripotent Stem Cells | 3 | 2023 | 276 | 1.730 |
Why?
| | Liver | 12 | 2024 | 1887 | 1.100 |
Why?
| | Ethanol | 10 | 2024 | 627 | 0.960 |
Why?
| | Oxidation-Reduction | 15 | 2025 | 1087 | 0.940 |
Why?
| | Aldehydes | 8 | 2017 | 142 | 0.910 |
Why?
| | Thioredoxins | 8 | 2018 | 30 | 0.910 |
Why?
| | Peroxiredoxin VI | 3 | 2009 | 9 | 0.870 |
Why?
| | Homocystinuria | 3 | 2024 | 62 | 0.870 |
Why?
| | Pesticides | 2 | 2018 | 63 | 0.860 |
Why?
| | Glutathione | 10 | 2023 | 375 | 0.850 |
Why?
| | Metabolome | 4 | 2018 | 384 | 0.780 |
Why?
| | Parkinson Disease | 3 | 2020 | 600 | 0.720 |
Why?
| | Energy Metabolism | 4 | 2025 | 935 | 0.720 |
Why?
| | Metabolomics | 5 | 2014 | 727 | 0.710 |
Why?
| | Oxidative Stress | 16 | 2025 | 1339 | 0.710 |
Why?
| | Neuroblastoma | 2 | 2020 | 174 | 0.680 |
Why?
| | Neural Stem Cells | 1 | 2023 | 166 | 0.660 |
Why?
| | Proteomics | 8 | 2025 | 1195 | 0.640 |
Why?
| | Dinoprostone | 1 | 2021 | 178 | 0.630 |
Why?
| | Cyclooxygenase 2 | 1 | 2021 | 165 | 0.630 |
Why?
| | Simvastatin | 1 | 2020 | 60 | 0.610 |
Why?
| | Mass Spectrometry | 5 | 2018 | 750 | 0.610 |
Why?
| | SNARE Proteins | 1 | 2019 | 40 | 0.610 |
Why?
| | Cysteine | 5 | 2024 | 210 | 0.610 |
Why?
| | Glycolysis | 3 | 2024 | 339 | 0.570 |
Why?
| | Pyruvaldehyde | 2 | 2019 | 50 | 0.560 |
Why?
| | Sulfinic Acids | 1 | 2018 | 6 | 0.550 |
Why?
| | Aminobutyrates | 1 | 2018 | 31 | 0.530 |
Why?
| | Peroxiredoxins | 4 | 2018 | 26 | 0.530 |
Why?
| | Taurine | 1 | 2018 | 41 | 0.530 |
Why?
| | Proteostasis Deficiencies | 1 | 2017 | 5 | 0.520 |
Why?
| | Autophagy | 1 | 2019 | 286 | 0.510 |
Why?
| | Liver Diseases, Alcoholic | 3 | 2024 | 97 | 0.490 |
Why?
| | Environmental Pollutants | 1 | 2018 | 167 | 0.480 |
Why?
| | Trisomy | 1 | 2017 | 78 | 0.480 |
Why?
| | Fibroblasts | 1 | 2021 | 1034 | 0.440 |
Why?
| | Paraquat | 2 | 2014 | 13 | 0.440 |
Why?
| | Mitochondrial Proteins | 3 | 2015 | 262 | 0.440 |
Why?
| | Lysine | 4 | 2024 | 302 | 0.440 |
Why?
| | Fungicides, Industrial | 1 | 2014 | 4 | 0.420 |
Why?
| | Callithrix | 1 | 2013 | 12 | 0.400 |
Why?
| | Saccharum | 2 | 2025 | 77 | 0.390 |
Why?
| | Thiolester Hydrolases | 2 | 2025 | 13 | 0.380 |
Why?
| | Nanoparticles | 3 | 2025 | 519 | 0.360 |
Why?
| | Carbon | 3 | 2024 | 203 | 0.350 |
Why?
| | Cystathionine beta-Synthase | 3 | 2024 | 65 | 0.340 |
Why?
| | Neurotoxins | 1 | 2011 | 28 | 0.340 |
Why?
| | Cross-Linking Reagents | 2 | 2009 | 207 | 0.340 |
Why?
| | Mice | 23 | 2024 | 18339 | 0.320 |
Why?
| | Lipid Metabolism | 3 | 2015 | 527 | 0.310 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2021 | 269 | 0.310 |
Why?
| | Cell Line, Tumor | 5 | 2020 | 3540 | 0.310 |
Why?
| | Superoxides | 1 | 2010 | 204 | 0.300 |
Why?
| | Mitochondrial Diseases | 1 | 2010 | 93 | 0.300 |
Why?
| | Reactive Oxygen Species | 4 | 2025 | 621 | 0.300 |
Why?
| | Humans | 40 | 2025 | 144759 | 0.290 |
Why?
| | Cell Line | 6 | 2025 | 2882 | 0.290 |
Why?
| | Hydrogen Peroxide | 1 | 2010 | 336 | 0.280 |
Why?
| | Animals | 27 | 2024 | 38058 | 0.270 |
Why?
| | Mice, Inbred C57BL | 14 | 2024 | 5992 | 0.270 |
Why?
| | Lactoylglutathione Lyase | 2 | 2025 | 19 | 0.260 |
Why?
| | Antioxidants | 3 | 2013 | 549 | 0.260 |
Why?
| | Proteome | 4 | 2025 | 518 | 0.250 |
Why?
| | Silicon Dioxide | 2 | 2025 | 121 | 0.250 |
Why?
| | Computational Biology | 3 | 2017 | 680 | 0.240 |
Why?
| | Phenylpropionates | 1 | 2025 | 27 | 0.230 |
Why?
| | Cells, Cultured | 3 | 2022 | 4154 | 0.230 |
Why?
| | Phosphoglycerate Dehydrogenase | 1 | 2025 | 6 | 0.220 |
Why?
| | Oxylipins | 1 | 2025 | 47 | 0.220 |
Why?
| | Alcohol Drinking | 2 | 2011 | 826 | 0.220 |
Why?
| | Protein Carbonylation | 3 | 2017 | 57 | 0.220 |
Why?
| | Pyrrolidines | 1 | 2025 | 125 | 0.220 |
Why?
| | Cell Differentiation | 2 | 2023 | 2050 | 0.210 |
Why?
| | Tetrahydrofolates | 1 | 2024 | 16 | 0.210 |
Why?
| | Tetrahydrofolate Dehydrogenase | 1 | 2024 | 23 | 0.210 |
Why?
| | Serine | 1 | 2025 | 145 | 0.210 |
Why?
| | Mitochondria, Liver | 3 | 2014 | 70 | 0.210 |
Why?
| | Kidney Tubules, Proximal | 1 | 2025 | 130 | 0.210 |
Why?
| | Blotting, Western | 3 | 2018 | 1187 | 0.200 |
Why?
| | Bronchi | 1 | 2025 | 267 | 0.200 |
Why?
| | Benzodioxoles | 1 | 2025 | 158 | 0.200 |
Why?
| | Phenotype | 1 | 2012 | 3162 | 0.200 |
Why?
| | Quinolones | 1 | 2025 | 201 | 0.190 |
Why?
| | Tandem Mass Spectrometry | 6 | 2023 | 576 | 0.190 |
Why?
| | Aminophenols | 1 | 2025 | 201 | 0.190 |
Why?
| | Male | 21 | 2024 | 72315 | 0.190 |
Why?
| | Aging | 1 | 2013 | 1966 | 0.180 |
Why?
| | Disease Models, Animal | 6 | 2024 | 4557 | 0.180 |
Why?
| | Hepatitis, Alcoholic | 1 | 2021 | 15 | 0.180 |
Why?
| | Pyrazoles | 1 | 2025 | 509 | 0.170 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2025 | 370 | 0.170 |
Why?
| | Indoles | 1 | 2025 | 501 | 0.170 |
Why?
| | Pyridines | 1 | 2025 | 605 | 0.170 |
Why?
| | Hematopoietic Stem Cells | 1 | 2024 | 420 | 0.170 |
Why?
| | Cyclooxygenase 1 | 1 | 2021 | 26 | 0.170 |
Why?
| | Superoxide Dismutase | 3 | 2017 | 301 | 0.170 |
Why?
| | Cystathionine gamma-Lyase | 1 | 2020 | 13 | 0.170 |
Why?
| | Thioredoxin-Disulfide Reductase | 2 | 2018 | 14 | 0.160 |
Why?
| | HT29 Cells | 2 | 2018 | 37 | 0.160 |
Why?
| | Hydrogen Sulfide | 1 | 2020 | 48 | 0.160 |
Why?
| | Mevalonic Acid | 1 | 2020 | 12 | 0.160 |
Why?
| | Mast Cells | 1 | 2021 | 146 | 0.160 |
Why?
| | Methionine | 1 | 2021 | 162 | 0.160 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2019 | 32 | 0.160 |
Why?
| | Protein Processing, Post-Translational | 3 | 2025 | 477 | 0.160 |
Why?
| | Immunoglobulin E | 1 | 2021 | 315 | 0.160 |
Why?
| | Ubiquinone | 1 | 2020 | 35 | 0.150 |
Why?
| | R-SNARE Proteins | 1 | 2019 | 19 | 0.150 |
Why?
| | Protein Transport | 2 | 2019 | 441 | 0.150 |
Why?
| | Zinc Oxide | 1 | 2019 | 10 | 0.150 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 684 | 0.150 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2020 | 191 | 0.150 |
Why?
| | Models, Animal | 2 | 2013 | 392 | 0.150 |
Why?
| | Epithelial Cells | 1 | 2025 | 1125 | 0.150 |
Why?
| | Lysosomes | 1 | 2019 | 128 | 0.150 |
Why?
| | Zebrafish | 1 | 2023 | 528 | 0.140 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2019 | 120 | 0.140 |
Why?
| | Cell Survival | 2 | 2019 | 1098 | 0.140 |
Why?
| | Microtubule-Associated Proteins | 1 | 2019 | 196 | 0.140 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2018 | 594 | 0.140 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2025 | 653 | 0.140 |
Why?
| | S-Nitrosothiols | 1 | 2018 | 5 | 0.140 |
Why?
| | Female | 13 | 2024 | 78271 | 0.140 |
Why?
| | gamma-Glutamyltransferase | 1 | 2018 | 42 | 0.130 |
Why?
| | Glutamate-Cysteine Ligase | 2 | 2023 | 20 | 0.130 |
Why?
| | Lipid Peroxidation | 4 | 2011 | 160 | 0.130 |
Why?
| | Electron Transport | 1 | 2018 | 118 | 0.130 |
Why?
| | Hepatitis | 1 | 2017 | 43 | 0.130 |
Why?
| | Acetylation | 4 | 2024 | 252 | 0.130 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2017 | 42 | 0.130 |
Why?
| | Mice, Transgenic | 3 | 2012 | 2182 | 0.130 |
Why?
| | Macrophages | 1 | 2024 | 1511 | 0.120 |
Why?
| | Amino Acids | 2 | 2018 | 521 | 0.120 |
Why?
| | Cochlea | 2 | 1994 | 73 | 0.120 |
Why?
| | End Stage Liver Disease | 1 | 2017 | 94 | 0.120 |
Why?
| | Apoptosis | 3 | 2020 | 2430 | 0.120 |
Why?
| | Adenosine Triphosphate | 1 | 2018 | 498 | 0.120 |
Why?
| | Skin | 1 | 2021 | 755 | 0.120 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 462 | 0.110 |
Why?
| | Cholestasis | 1 | 2018 | 219 | 0.110 |
Why?
| | Oxygen Consumption | 1 | 2018 | 724 | 0.110 |
Why?
| | Recombinant Proteins | 2 | 2019 | 1370 | 0.110 |
Why?
| | Glycoproteins | 2 | 2021 | 355 | 0.110 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 375 | 0.110 |
Why?
| | Atrazine | 1 | 2014 | 7 | 0.110 |
Why?
| | alpha-Linolenic Acid | 1 | 2014 | 8 | 0.110 |
Why?
| | Gene Expression Regulation | 3 | 2019 | 2608 | 0.110 |
Why?
| | Herbicides | 1 | 2014 | 27 | 0.110 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2017 | 266 | 0.110 |
Why?
| | Metabolic Networks and Pathways | 2 | 2013 | 187 | 0.110 |
Why?
| | Otoacoustic Emissions, Spontaneous | 1 | 1994 | 7 | 0.110 |
Why?
| | Infant | 2 | 2019 | 10034 | 0.100 |
Why?
| | Tyrosine | 1 | 2014 | 222 | 0.100 |
Why?
| | Cadmium | 1 | 2014 | 69 | 0.100 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2018 | 365 | 0.100 |
Why?
| | Tryptophan | 1 | 2014 | 181 | 0.100 |
Why?
| | Endothelial Cells | 1 | 2019 | 869 | 0.100 |
Why?
| | Betaine | 2 | 2024 | 65 | 0.090 |
Why?
| | Azoles | 1 | 2012 | 4 | 0.090 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2014 | 179 | 0.090 |
Why?
| | Phenylenediamines | 1 | 2012 | 12 | 0.090 |
Why?
| | Organoselenium Compounds | 1 | 2012 | 11 | 0.090 |
Why?
| | Kidney | 2 | 2023 | 1495 | 0.090 |
Why?
| | Auditory Perception | 1 | 1993 | 114 | 0.090 |
Why?
| | Chromatography, Liquid | 4 | 2017 | 454 | 0.090 |
Why?
| | Esthetics | 1 | 1992 | 41 | 0.090 |
Why?
| | Homocysteine | 2 | 2024 | 151 | 0.090 |
Why?
| | Alkylation | 1 | 2012 | 27 | 0.090 |
Why?
| | Amino Acids, Sulfur | 1 | 2011 | 8 | 0.090 |
Why?
| | Surgery, Plastic | 1 | 1992 | 52 | 0.090 |
Why?
| | Otitis Media | 1 | 1994 | 181 | 0.090 |
Why?
| | Fatty Liver, Alcoholic | 1 | 2011 | 14 | 0.090 |
Why?
| | Immunoassay | 1 | 2012 | 109 | 0.090 |
Why?
| | Sweetening Agents | 1 | 2011 | 57 | 0.090 |
Why?
| | Folic Acid | 2 | 2024 | 199 | 0.080 |
Why?
| | Fructose | 1 | 2011 | 130 | 0.080 |
Why?
| | Regression Analysis | 1 | 2013 | 1003 | 0.080 |
Why?
| | Neurotoxicity Syndromes | 1 | 2011 | 38 | 0.080 |
Why?
| | Sirtuin 3 | 1 | 2011 | 60 | 0.080 |
Why?
| | Cytochromes c | 1 | 2010 | 53 | 0.080 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2011 | 95 | 0.080 |
Why?
| | Triglycerides | 2 | 2011 | 520 | 0.080 |
Why?
| | Hepatocytes | 1 | 2011 | 223 | 0.080 |
Why?
| | Biomarkers | 3 | 2021 | 4271 | 0.080 |
Why?
| | Cardiolipins | 1 | 2010 | 82 | 0.080 |
Why?
| | Buthionine Sulfoximine | 2 | 2023 | 9 | 0.080 |
Why?
| | Multivariate Analysis | 1 | 2013 | 1539 | 0.080 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2011 | 157 | 0.080 |
Why?
| | Apolipoprotein B-100 | 1 | 2009 | 13 | 0.070 |
Why?
| | Dietary Fats | 1 | 2011 | 314 | 0.070 |
Why?
| | Fatty Liver | 1 | 2011 | 251 | 0.070 |
Why?
| | Phylogeny | 1 | 2013 | 1016 | 0.070 |
Why?
| | Cytochrome P-450 CYP2E1 | 1 | 2008 | 30 | 0.070 |
Why?
| | Animal Feed | 1 | 2008 | 53 | 0.070 |
Why?
| | Endoplasmic Reticulum | 1 | 2011 | 266 | 0.070 |
Why?
| | NF-kappa B | 2 | 2011 | 661 | 0.070 |
Why?
| | Molecular Conformation | 1 | 2008 | 148 | 0.070 |
Why?
| | Dopamine | 1 | 2011 | 283 | 0.070 |
Why?
| | Alcoholism | 1 | 2015 | 817 | 0.070 |
Why?
| | Infant, Newborn | 1 | 2019 | 6429 | 0.070 |
Why?
| | Cell Nucleus | 1 | 2011 | 618 | 0.070 |
Why?
| | Pilot Projects | 1 | 2013 | 1886 | 0.070 |
Why?
| | Protein Binding | 1 | 2014 | 2273 | 0.070 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2008 | 292 | 0.060 |
Why?
| | Models, Molecular | 2 | 2011 | 1618 | 0.060 |
Why?
| | Head and Neck Neoplasms | 1 | 1992 | 558 | 0.060 |
Why?
| | Oxygen | 1 | 2012 | 995 | 0.060 |
Why?
| | Glutathione Transferase | 2 | 2017 | 100 | 0.060 |
Why?
| | Glucose | 1 | 2011 | 1047 | 0.060 |
Why?
| | Sex Factors | 1 | 2012 | 2112 | 0.060 |
Why?
| | Disease Progression | 1 | 2013 | 2847 | 0.060 |
Why?
| | Glycosylation | 2 | 2019 | 172 | 0.060 |
Why?
| | Polymerase Chain Reaction | 1 | 2008 | 1054 | 0.060 |
Why?
| | Signal Transduction | 3 | 2018 | 5226 | 0.060 |
Why?
| | Influenza, Human | 1 | 2011 | 616 | 0.050 |
Why?
| | Skin Neoplasms | 1 | 1992 | 847 | 0.050 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1716 | 0.050 |
Why?
| | Drug Combinations | 1 | 2025 | 390 | 0.050 |
Why?
| | Case-Control Studies | 3 | 2018 | 3604 | 0.050 |
Why?
| | RNA, Messenger | 2 | 2011 | 2832 | 0.050 |
Why?
| | Phosphorylation | 1 | 2008 | 1732 | 0.050 |
Why?
| | Gene Expression | 1 | 2008 | 1490 | 0.050 |
Why?
| | Particle Size | 1 | 2025 | 411 | 0.050 |
Why?
| | HEK293 Cells | 2 | 2019 | 744 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 1 | 2008 | 2527 | 0.050 |
Why?
| | Click Chemistry | 1 | 2023 | 51 | 0.050 |
Why?
| | Transcription Factors | 1 | 2011 | 1741 | 0.050 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2023 | 139 | 0.050 |
Why?
| | Glutathione Disulfide | 2 | 2013 | 32 | 0.050 |
Why?
| | Acoustic Stimulation | 2 | 1994 | 333 | 0.050 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2024 | 239 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2009 | 3121 | 0.040 |
Why?
| | Neurons | 1 | 2011 | 1640 | 0.040 |
Why?
| | Mammals | 1 | 2023 | 293 | 0.040 |
Why?
| | Eye Proteins | 1 | 2021 | 90 | 0.040 |
Why?
| | Adenosylhomocysteinase | 1 | 2021 | 9 | 0.040 |
Why?
| | Glycine Hydroxymethyltransferase | 1 | 2021 | 16 | 0.040 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2021 | 35 | 0.040 |
Why?
| | Polyamines | 1 | 2021 | 42 | 0.040 |
Why?
| | Diet | 1 | 2008 | 1273 | 0.040 |
Why?
| | Adult | 5 | 2017 | 40449 | 0.040 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2023 | 449 | 0.040 |
Why?
| | Uterine Artery | 1 | 2020 | 75 | 0.040 |
Why?
| | Rats | 1 | 2008 | 5597 | 0.040 |
Why?
| | Carrier Proteins | 2 | 2017 | 737 | 0.040 |
Why?
| | Aged | 3 | 2017 | 25913 | 0.040 |
Why?
| | Seizures | 1 | 2023 | 460 | 0.040 |
Why?
| | Alkynes | 1 | 2019 | 66 | 0.040 |
Why?
| | Inflammation | 1 | 2011 | 2878 | 0.040 |
Why?
| | Amino Acid Sequence | 2 | 2015 | 2155 | 0.040 |
Why?
| | Solubility | 1 | 2019 | 242 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2021 | 496 | 0.040 |
Why?
| | Molecular Sequence Data | 2 | 2015 | 2930 | 0.040 |
Why?
| | Autoimmunity | 1 | 2024 | 926 | 0.030 |
Why?
| | Surface Properties | 1 | 2019 | 410 | 0.030 |
Why?
| | Heme Oxygenase-1 | 1 | 2018 | 74 | 0.030 |
Why?
| | Estrogens | 1 | 2020 | 380 | 0.030 |
Why?
| | Azo Compounds | 1 | 2017 | 30 | 0.030 |
Why?
| | Middle Aged | 3 | 2017 | 35875 | 0.030 |
Why?
| | Catalase | 1 | 2017 | 130 | 0.030 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2017 | 76 | 0.030 |
Why?
| | Homeostasis | 1 | 2020 | 640 | 0.030 |
Why?
| | Chronic Disease | 2 | 2011 | 1813 | 0.030 |
Why?
| | Glutathione Reductase | 1 | 2015 | 25 | 0.030 |
Why?
| | Cystic Fibrosis | 1 | 2025 | 1158 | 0.030 |
Why?
| | Retrospective Studies | 1 | 2013 | 17066 | 0.030 |
Why?
| | Toxicity Tests, Acute | 1 | 2014 | 7 | 0.030 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2014 | 88 | 0.030 |
Why?
| | Tympanoplasty | 1 | 1994 | 9 | 0.030 |
Why?
| | Ossicular Prosthesis | 1 | 1994 | 13 | 0.030 |
Why?
| | Hearing Loss, Conductive | 1 | 1994 | 24 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2015 | 210 | 0.030 |
Why?
| | Fourier Analysis | 1 | 2014 | 41 | 0.030 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2014 | 39 | 0.030 |
Why?
| | Acoustics | 1 | 1994 | 48 | 0.030 |
Why?
| | Auranofin | 1 | 2013 | 6 | 0.030 |
Why?
| | Amplifiers, Electronic | 1 | 1993 | 7 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 1994 | 5408 | 0.020 |
Why?
| | Auditory Threshold | 1 | 1993 | 51 | 0.020 |
Why?
| | Ear, Middle | 1 | 1993 | 85 | 0.020 |
Why?
| | DNA Primers | 1 | 2014 | 512 | 0.020 |
Why?
| | Noise | 1 | 1993 | 71 | 0.020 |
Why?
| | Isoindoles | 1 | 2012 | 5 | 0.020 |
Why?
| | Facial Neoplasms | 1 | 1992 | 19 | 0.020 |
Why?
| | Prosthesis Design | 1 | 1994 | 357 | 0.020 |
Why?
| | Administration, Oral | 1 | 2014 | 847 | 0.020 |
Why?
| | Hearing | 1 | 1993 | 132 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 983 | 0.020 |
Why?
| | Nuclear Localization Signals | 1 | 2011 | 17 | 0.020 |
Why?
| | Biological Assay | 1 | 2011 | 128 | 0.020 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2011 | 110 | 0.020 |
Why?
| | Metabolic Detoxication, Phase I | 1 | 2010 | 6 | 0.020 |
Why?
| | Time Factors | 2 | 2014 | 7173 | 0.020 |
Why?
| | Microsomes, Liver | 1 | 2011 | 85 | 0.020 |
Why?
| | Surgical Flaps | 1 | 1992 | 142 | 0.020 |
Why?
| | Molecular Structure | 1 | 2012 | 499 | 0.020 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2010 | 50 | 0.020 |
Why?
| | NAD | 1 | 2011 | 81 | 0.020 |
Why?
| | Stereoisomerism | 1 | 2010 | 104 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2011 | 366 | 0.020 |
Why?
| | Orthomyxoviridae Infections | 1 | 2011 | 72 | 0.020 |
Why?
| | Cytoplasm | 1 | 2011 | 269 | 0.020 |
Why?
| | Base Sequence | 1 | 2014 | 2190 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 2027 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2013 | 824 | 0.020 |
Why?
| | Protein Subunits | 1 | 2010 | 226 | 0.020 |
Why?
| | Wound Healing | 1 | 1992 | 351 | 0.020 |
Why?
| | Intracellular Space | 1 | 2009 | 66 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2010 | 919 | 0.020 |
Why?
| | Tubulin | 1 | 2009 | 147 | 0.020 |
Why?
| | Pregnancy | 1 | 2020 | 7190 | 0.020 |
Why?
| | Cell Death | 1 | 2009 | 383 | 0.020 |
Why?
| | Glucocorticoids | 1 | 2011 | 535 | 0.020 |
Why?
| | Microtubules | 1 | 2009 | 286 | 0.020 |
Why?
| | Models, Biological | 1 | 1994 | 1821 | 0.020 |
Why?
| | Neoplasm Recurrence, Local | 1 | 1992 | 1137 | 0.010 |
Why?
| | Weight Loss | 1 | 2011 | 836 | 0.010 |
Why?
| | Lipids | 1 | 2009 | 710 | 0.010 |
Why?
| | Cytokines | 1 | 2011 | 2061 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2009 | 2496 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 1992 | 8265 | 0.010 |
Why?
|
|
Roede's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|